Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial

AIMS: To examine associations of below-target and target dose of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, with outcomes in patients with heart failure and reduced ejection fraction (HFrEF) in the Studies of Left Ventricular Dysfunction (SOLVD) Treatment trial. METHODS AND RESULTS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Heart Fail
Hlavní autoři: Lam, Phillip H., Dooley, Daniel J., Fonarow, Gregg C., Butler, Javed, Bhatt, Deepak L., Filippatos, Gerasimos S., Deedwania, Prakash, Forman, Daniel E., White, Michel, Fletcher, Ross D., Arundel, Cherinne, Blackman, Marc R., Adamopoulos, Chris, Kanonidis, Ioannis E., Aban, Inmaculada B., Patel, Kanan, Aronow, Wilbert S., Allman, Richard M., Anker, Stefan D., Pitt, Bertram, Ahmed, Ali
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500736/
https://ncbi.nlm.nih.gov/pubmed/28980368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.937
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky